NovoCure Ltd (MEX:NVCR)
MXN 275.39 0 (0%) Market Cap: 37.39 Bil Enterprise Value: 31.76 Bil PE Ratio: 0 PB Ratio: 5.23 GF Score: 69/100

Q4 2021 Novocure Ltd Earnings Call Transcript

Feb 24, 2022 / 01:00PM GMT
Release Date Price: MXN1521.03
Operator

Good day, and thank you for standing by. Welcome to the NovoCure Fourth Quarter and Full Year 2021 Earnings Conference Call. (Operator Instructions) Please be advised today's conference may be recorded. (Operator Instructions)

I'd now like to hand the conference over to Ingrid Goldberg. Please go ahead.

Ingrid Goldberg
NovoCure Limited - VP of IR

Good morning, and thank you for joining us to review NovoCure's Fourth Quarter and Full Year 2021 performance. I'm joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A.

The slides presented today can be viewed on our website, www.novocure.com, by clicking on the link for fourth quarter and full year 2021 financial results located in the Quarterly Reports section of our Investor Relations page.

Before we begin, I would like to remind you that our discussions during this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot